Project PHOENIX: Molecular Signatures of Burn Pit Exposure
← catalyst calendarNCT07562243 · readout in 986 d
Sponsored by Creative Medical Technology Holdings Inc (industry) · CELZ — their whole pipeline →. With WCG IRB.
Phase
—
Status
Not yet recruiting
Study type
Observational
Enrollment
1,000estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-05-01 | estimated | When the study began enrolling |
| Primary completion | 2029-05-01 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2031-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2026-05-01 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-05-01 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Burn Pit Exposure
- Airborne Hazard Exposure
- Veteran Health
- Deployment-Related Toxic Exposure
- Biomarkers
- Immune Dysfunction
- Respiratory Symptoms
Interventions
- Other: Prior Burn Pit Exposure
- Other: No Known Burn Pit Exposure
Primary outcome
what the primary-completion date above is the date OFDifferential gene expression (RNA-seq normalized counts) between burn pit-exposed and unexposed cohorts
measured Baseline
Permalink · CELZ's whole pipeline · Catalyst calendar · Every registered study · What changed